2 studies found for:    22623692 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Conditions: Breast Neoplasms;   Breast Cancer;   Breast Tumors
Interventions: Drug: Standard Therapy;   Drug: AMG 386 with or without Trastuzumab;   Drug: AMG 479 (Ganitumab) plus Metformin;   Drug: MK-2206 with or without Trastuzumab;   Drug: AMG 386 and Trastuzumab;   Drug: T-DM1 and Pertuzumab;   Drug: Pertuzumab and Trastuzumab;   Drug: Ganetespib;   Drug: ABT-888;   Drug: Neratinib;   Drug: PLX3397;   Drug: Pembrolizumab;   Drug: Talazoparib plus Irinotecan
2 Completed Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: MRI/MRS;   Radiation: gadopentetate dimeglumine

Indicates status has not been verified in more than two years